Pain Injection vs Epidural Anesthesia for Hip Surgery in Children with Cerebral Palsy
Trial Summary
What is the purpose of this trial?
Pain management in pediatric patients presents a difficult challenge. Unlike adults, pediatric patients often cannot communicate their pain management needs clearly. This is especially true in patients with cerebral palsy (CP), who often have concomitant developmental delay, intellectual disability and verbal limitations. Current literature indicates pain as a common experience for children with CP but has been understudied in this population. Moreover, inadequate post-operative pain control can result in negative physiologic and psychological complications and lead to poor surgical outcomes. Currently, perioperative pain management following orthopaedic procedures in pediatric patients follows traditional protocols that rely on the administration of opioid medications despite their known adverse side effects including nausea, vomiting, itching, constipation, urinary retention, confusion, and respiratory depression. Epidural anesthesia is a key modality in traditional pain management for pediatric patients with CP given its proven efficacy in decreasing pain and managing spasticity. Yet, administering epidural anesthesia in this patient population poses several risks including damage to preexisting intrathecal baclofen pumps, iatrogenic infection, and technically demanding insertion given high rates of concomitant neuromuscular scoliosis. Alternatively, multimodal analgesic injections theoretically offer an efficacious adjunct to traditional pain management protocols with a lower risk profile. Preliminary data from our study group's pilot randomized control trial comparing the safety and efficacy of a multimodal surgical site injection to placebo showed decreased pain scores and narcotic consumption postoperatively in this patient population. Based on these promising results, the objective of this randomized control trial is to evaluate the efficacy of a multimodal surgical site injection compared to epidural anesthesia for postoperative pain control following operative management of hip dysplasia in pediatric patients with CP.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are currently using opioids.
What data supports the effectiveness of the treatment Epidural Anesthesia for hip surgery in children with cerebral palsy?
Research shows that epidural anesthesia provides excellent pain relief for children with cerebral palsy undergoing hip surgery, as it offers continuous pain relief and reduces the need for other pain medications. It is considered superior to local infiltration analgesia for managing postoperative pain in these patients.12345
Is regional anesthesia safe for children undergoing surgery?
Regional anesthesia, including epidural anesthesia, is generally safe for children, with large studies showing a low rate of complications. While serious complications like neurologic injury are rare, they are more likely with central blocks than peripheral ones, and experienced anesthesiologists can manage them effectively.12678
How does the treatment for hip surgery in children with cerebral palsy differ from other treatments?
The treatment using epidural anesthesia and pain injection for hip surgery in children with cerebral palsy is unique because it combines regional anesthesia techniques to manage pain effectively while minimizing the use of opioids. This approach is particularly beneficial due to the complex nerve structure around the hip joint, providing comprehensive pain relief without the need for multiple injections.910111213
Research Team
Rachel M Thompson, MD
Principal Investigator
University of California, Los Angeles
Eligibility Criteria
This trial is for pediatric patients with cerebral palsy who are undergoing hip surgery. It's aimed at those who may have difficulty communicating their pain due to developmental delays or intellectual disabilities. Patients must be suitable candidates for either epidural anesthesia or surgical site injections.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either epidural anesthesia or a multimodal surgical site injection during hip surgery
Postoperative Monitoring
Participants' pain scores and narcotic consumption are monitored in the post-anesthesia care unit and inpatient ward
Follow-up
Participants are monitored for safety and effectiveness after treatment, including parent satisfaction assessment
Treatment Details
Interventions
- Epidural Anesthesia (Procedure)
- Pain Injection (Procedure)
Epidural Anesthesia is already approved in Canada for the following indications:
- Pain management for surgical procedures
- Postoperative pain control
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Los Angeles
Lead Sponsor
Dr. Thomas Rando
University of California, Los Angeles
Chief Medical Officer since 2023
MD from UCLA
Amir Naiberg
University of California, Los Angeles
Chief Executive Officer since 2024
JD from UCLA
Northwestern University
Collaborator
Dr. Jeffrey Sherman
Northwestern University
Chief Medical Officer
MD from Northwestern University
Dr. Alicia Löffler
Northwestern University
Chief Executive Officer since 2010
PhD from the University of Massachusetts at Amherst, post-doctoral training at Caltech